This is a laboratory testing study using the SARS-Cov2 Virus IgG/IgM rapid test cassette Clungene test to determine the presence of IgM and IgG antibodies in subjects who have tested negative or positive for COVID-19. The study is observational and subjects will be assigned to one of two arms depending on the results of their nCOVID-19 test.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Received confirmed COVID-19 positive or negative test from Sharp HealthCare's standard method of testing.
Age \>/=18 years old.
Access to a phone in the hospital room or an electronic device that is capable of receiving phone calls and/or video calls and/or e-mail.
Able to read/write/speak English or Spanish fluently.
Subjects must have the ability to understand the requirements of the study, provide informed consent, and provide authorization of use and disclosure of personal health information.
Hospitalized at the time of consent or recently discharged with leftover blood stored at hospital laboratory
You may not be if
Impaired cognitive or decision-making capacity (based on the clinical judgment of the PI or designee)
